ATE235895T1 - Arzneistoff-abgabesystem enthaltend eine festgepackte, feste arzneistoffbasis - Google Patents

Arzneistoff-abgabesystem enthaltend eine festgepackte, feste arzneistoffbasis

Info

Publication number
ATE235895T1
ATE235895T1 AT99953285T AT99953285T ATE235895T1 AT E235895 T1 ATE235895 T1 AT E235895T1 AT 99953285 T AT99953285 T AT 99953285T AT 99953285 T AT99953285 T AT 99953285T AT E235895 T1 ATE235895 T1 AT E235895T1
Authority
AT
Austria
Prior art keywords
packed
hard
delivery system
system containing
drug
Prior art date
Application number
AT99953285T
Other languages
English (en)
Inventor
Wolfgang Fleischer
Karen Reimer
Hans Schreier
Original Assignee
Euro Celtique Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Euro Celtique Sa filed Critical Euro Celtique Sa
Application granted granted Critical
Publication of ATE235895T1 publication Critical patent/ATE235895T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/127—Liposomes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/02—Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/02—Nasal agents, e.g. decongestants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/04—Drugs for disorders of the respiratory system for throat disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P23/00—Anaesthetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/02—Local antiseptics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A61P31/06—Antibacterial agents for tuberculosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
AT99953285T 1998-05-27 1999-05-27 Arzneistoff-abgabesystem enthaltend eine festgepackte, feste arzneistoffbasis ATE235895T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US8689598P 1998-05-27 1998-05-27
PCT/EP1999/003680 WO1999061003A1 (en) 1998-05-27 1999-05-27 Drug delivery system comprising a tightly compacted solid medicament stock

Publications (1)

Publication Number Publication Date
ATE235895T1 true ATE235895T1 (de) 2003-04-15

Family

ID=22201600

Family Applications (3)

Application Number Title Priority Date Filing Date
AT99926448T ATE339187T1 (de) 1998-05-27 1999-05-27 Verwendung von zusammensetzungen mit antiseptika und/oder die wundheilung fördernden wirkstoffen für den tieferen atemwegstrakt
AT99953285T ATE235895T1 (de) 1998-05-27 1999-05-27 Arzneistoff-abgabesystem enthaltend eine festgepackte, feste arzneistoffbasis
AT99926446T ATE319427T1 (de) 1998-05-27 1999-05-27 Zusammensetzungen zur anwendung von entzündungshemmenden, insbesondere antiseptischen und/oder wundheilenden wirkstoffen im oberen atemwegtrakt und/oder ohr

Family Applications Before (1)

Application Number Title Priority Date Filing Date
AT99926448T ATE339187T1 (de) 1998-05-27 1999-05-27 Verwendung von zusammensetzungen mit antiseptika und/oder die wundheilung fördernden wirkstoffen für den tieferen atemwegstrakt

Family Applications After (1)

Application Number Title Priority Date Filing Date
AT99926446T ATE319427T1 (de) 1998-05-27 1999-05-27 Zusammensetzungen zur anwendung von entzündungshemmenden, insbesondere antiseptischen und/oder wundheilenden wirkstoffen im oberen atemwegtrakt und/oder ohr

Country Status (19)

Country Link
US (2) US20080038330A1 (de)
EP (3) EP1083886B1 (de)
JP (3) JP4741727B2 (de)
KR (3) KR100445146B1 (de)
CN (3) CN1303271A (de)
AT (3) ATE339187T1 (de)
AU (3) AU752018C (de)
BR (3) BR9911071A (de)
CA (3) CA2332371A1 (de)
CY (1) CY1105834T1 (de)
DE (6) DE69930259T2 (de)
DK (2) DK1079807T3 (de)
ES (2) ES2260915T3 (de)
HK (2) HK1035335A1 (de)
HU (3) HU226729B1 (de)
IL (4) IL139230A0 (de)
PT (2) PT1079806E (de)
RU (3) RU2211693C2 (de)
WO (3) WO1999061003A1 (de)

Families Citing this family (70)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2000072823A1 (en) 1999-05-27 2000-12-07 Euroceltique S.A. Preparations for the application of anti-inflammatory agents
US7297344B1 (en) 1999-05-27 2007-11-20 Euro-Celtique, S.A. Preparations for the promotion of wound healing in the upper respiratory tract and/or ear
ES2341532T3 (es) 1999-05-27 2010-06-22 Euro-Celtique S.A. Preparacion con povidona yodada para el tratamiento de heridas.
US7300667B1 (en) 1999-05-27 2007-11-27 Euro-Celtique, S.A. Preparations for the application of anti-inflammatory, especially antiseptic agents and/or agents promoting the healing of wounds, to the lower respiratory tract
AP1665A (en) * 2000-02-08 2006-09-22 Euro Celtique Sa Tamper-resistant oral opioid agonist formulations.
US6989157B2 (en) * 2000-07-27 2006-01-24 Nucryst Pharmaceuticals Corp. Dry powders of metal-containing compounds
CA2432319A1 (en) 2000-12-21 2002-07-18 Nektar Therapeutics Pulmonary delivery of polyene antifungal agents
US6667344B2 (en) 2001-04-17 2003-12-23 Dey, L.P. Bronchodilating compositions and methods
US20030055026A1 (en) 2001-04-17 2003-03-20 Dey L.P. Formoterol/steroid bronchodilating compositions and methods of use thereof
DE10125731A1 (de) * 2001-05-17 2003-03-06 A I D Autoimmun Diagnostika Gm Darreichungsform von immunologischen Wirkstoffen
DE10141650C1 (de) 2001-08-24 2002-11-28 Lohmann Therapie Syst Lts Transdermales Therapeutisches System mit Fentanyl bzw. verwandten Substanzen
JPWO2003077891A1 (ja) * 2002-03-18 2005-07-14 アステラス製薬株式会社 吸入用粉末医薬組成物およびその製造方法
US7718189B2 (en) 2002-10-29 2010-05-18 Transave, Inc. Sustained release of antiinfectives
EP1561467A4 (de) * 2002-11-11 2008-06-25 Kowa Co Zusammensetzung zur wiederherstellung geschädigter haut
WO2004066975A1 (en) 2002-12-18 2004-08-12 Hough Ear Institute Otologic nanotechnology
EP1449520A1 (de) * 2003-02-24 2004-08-25 Euro-Celtique S.A. Verwendung von PVP-Jod zur Behandlung von Herpes
ES2292874T3 (es) 2003-05-19 2008-03-16 Euro-Celtique S.A. Composiciones liposomales secas de pvp-yodo.
US8651113B2 (en) 2003-06-18 2014-02-18 Swr&D Inc. Magnetically responsive nanoparticle therapeutic constructs and methods of making and using
US7344491B1 (en) 2003-11-26 2008-03-18 Nanobiomagnetics, Inc. Method and apparatus for improving hearing
US7723311B2 (en) 2003-06-18 2010-05-25 Nanobiomagnetics, Inc. Delivery of bioactive substances to target cells
TWI359675B (en) 2003-07-10 2012-03-11 Dey L P Bronchodilating β-agonist compositions
US20050058673A1 (en) 2003-09-09 2005-03-17 3M Innovative Properties Company Antimicrobial compositions and methods
US9028852B2 (en) 2004-09-07 2015-05-12 3M Innovative Properties Company Cationic antiseptic compositions and methods of use
FR2878746B1 (fr) 2004-12-02 2007-02-23 Vetoquinol Sa Sa Nouvelle composition pharmaceutique utilisable dans le domaine des vaccins
EP2497459B1 (de) 2005-03-10 2019-04-24 3M Innovative Properties Company Verfahren zur Reduktion von mikrobieller Kontamination
CN101137357B (zh) 2005-03-10 2012-07-04 3M创新有限公司 含有羟基羧酸的酯的抗微生物组合物
US8226975B2 (en) 2005-12-08 2012-07-24 Insmed Incorporated Lipid-based compositions of antiinfectives for treating pulmonary infections and methods of use thereof
DE102006011314A1 (de) 2006-03-11 2007-10-18 Peter Dr. Engels Kosmetische Zubereitungen mit einem Zusatz aus der Baobab-Pflanze
MX2008012794A (es) * 2006-04-03 2008-10-15 Teva Pharma Microparticulas de farmacos.
RU2315593C1 (ru) * 2006-08-02 2008-01-27 Открытое Акционерное Общество Завод Экологической Техники И Экопитания "Диод" Липосомальная композиция антиоксидантов для ингаляций при заболеваниях легких и верхних дыхательных путей
US8268347B1 (en) * 2006-10-24 2012-09-18 Aradigm Corporation Dual action, inhaled formulations providing both an immediate and sustained release profile
US8119156B2 (en) 2006-10-24 2012-02-21 Aradigm Corporation Dual action, inhaled formulations providing both an immediate and sustained release profile
US8071127B2 (en) 2006-10-24 2011-12-06 Aradigm Corporation Dual action, inhaled formulations providing both an immediate and sustained release profile
CA2667307C (en) 2006-10-27 2015-12-01 3M Innovative Properties Company Antimicrobial compositions comprising a c2-c5 lower alcohol, a cationic antimicrobial agent, and a fatty component containing free hydroxyl groups
WO2008137717A1 (en) 2007-05-04 2008-11-13 Transave, Inc. Compositions of multicationic drugs for reducing interactions with polyanionic biomolecules and methods and uses thereof
US9114081B2 (en) 2007-05-07 2015-08-25 Insmed Incorporated Methods of treating pulmonary disorders with liposomal amikacin formulations
US9119783B2 (en) 2007-05-07 2015-09-01 Insmed Incorporated Method of treating pulmonary disorders with liposomal amikacin formulations
US9333214B2 (en) 2007-05-07 2016-05-10 Insmed Incorporated Method for treating pulmonary disorders with liposomal amikacin formulations
PL2222314T3 (pl) * 2007-11-23 2013-07-31 Pharmalundensis Ab Zastosowanie i sposoby uzyskania rozluźnienia oskrzeli
US8865227B2 (en) 2007-12-20 2014-10-21 Smith & Nephew (Overseas) Limited Metal carbonate particles and methods of making thereof
KR20100048751A (ko) * 2008-10-31 2010-05-11 주식회사 동성바이오레인 스프레이 가능한 캡슐화된 기능성 미립자 조성물과 그 제조방법
NL2002442C2 (nl) 2009-01-22 2010-07-26 Weezenbeek Specialties B V Van Werkwijze voor het verjongen van een bitumen bevattende samenstelling.
EP2226073A1 (de) 2009-03-02 2010-09-08 Euro-Celtique S.A. Topische pharmazeutische Zusammensetzungen enthaltend ein Antiseptikum und Arginin zur Wundheilung
US20110086084A1 (en) * 2009-10-13 2011-04-14 David William Koenig Active Agent Containing Polymer Network Delivery Composition and Articles Using the Same
DK2722053T3 (da) 2010-12-30 2017-11-20 Aktsionernoye Obshchestvo Nauchnyi Tsentr Protivoinfektsionnyh Preparatov Antibakterielt middel til behandling af infektionssygdomme af bakteriel oprindelse
US9925251B2 (en) 2011-10-19 2018-03-27 President And Fellows Of Harvard College Treatments for Mycobacterium tuberculosis
KR101860485B1 (ko) * 2011-11-03 2018-07-02 (주)아모레퍼시픽 미세 유화 입자를 포함하는 미용 티슈, 그 제조방법 및 사용방법
LT2852391T (lt) 2012-05-21 2022-03-10 Insmed Incorporated Plaučių infekcijų gydymo būdai
EP2925298B1 (de) 2012-11-29 2019-05-29 Insmed Incorporated Stabilisierte vancomycin-formulierungen
RU2538433C1 (ru) * 2013-06-11 2015-01-10 Закрытое акционерное общество "ФИРН М" (ЗАО ФИРН М") Фармацевтическая композиция для профилактики и лечения инфекционно-воспалительных заболеваний различной этиологии путем оромукозного введения
US9987227B2 (en) 2013-10-22 2018-06-05 Aradigm Corporation Inhaled surfactant-modified liposomal formulations providing both an immediate and sustained release profile
RU2550932C1 (ru) * 2014-03-18 2015-05-20 Александр Александрович Кролевец Способ получения нанокапсул цефалоспориновых антибиотиков в ксантановой камеди
US20160120806A1 (en) * 2014-04-08 2016-05-05 Aradigm Corporation Nanocrystals formed in a microenvironment
US9532986B2 (en) 2014-04-08 2017-01-03 Aradigm Corporation Liposomal ciprofloxacin formulations with activity against non-tuberculous mycobacteria
US9968555B2 (en) * 2014-04-08 2018-05-15 Aradigm Corporation Liposomal formulations that form drug nanocrystals after freeze-thaw
NZ726256A (en) 2014-05-15 2022-11-25 Insmed Inc Methods for treating pulmonary non-tuberculous mycobacterial infections
US11000542B2 (en) 2014-07-23 2021-05-11 Firebrick Pharma Limited Treatment and prevention of the common cold using povidone-iodine
KR102086150B1 (ko) 2017-04-10 2020-03-06 부산대학교 산학협력단 하이드로겔화 되는 창상 치료용 파우더 조성물 및 이의 제조방법
FR3066115B1 (fr) 2017-05-10 2019-06-28 Universite de Bordeaux Comprimes de vecteurs d'acides nucleiques
US20200289552A1 (en) * 2017-07-04 2020-09-17 Fluchem Ltd Solid composition comprising iodine agent and sodium chloride having improved water solubility, and antiviral and antimicrobial composition for eye, oral cavity, nasal cavity or inhalation containing aqueous solution thereof
KR101935250B1 (ko) * 2017-07-04 2019-01-04 김대황 요오드제 및 삼투성 미각제를 포함하는 눈, 구강용, 비강용 또는 흡입용 항바이러스 및 항균 조성물
WO2019009630A1 (ko) * 2017-07-04 2019-01-10 김대황 수용해성이 향상된 요오드제 및 염화나트륨을 포함하는 고체 조성물 및 이의 수용액을 포함하는 눈, 구강용, 비강용 또는 흡입용 항바이러스 및 항균 조성물
KR102026805B1 (ko) 2017-12-12 2019-11-04 주식회사 크로파세 항염 화장료 조성물
EP3773505A4 (de) 2018-03-30 2021-12-22 Insmed Incorporated Verfahren zur kontinuierlichen herstellung von liposomalen arzneimittelprodukten
EP3781151A1 (de) * 2018-04-17 2021-02-24 Université de Caen Normandie Bambuterol zur behandlung von morbus alzheimer
RU2730834C1 (ru) * 2020-01-17 2020-08-26 Александр Александрович Кролевец Способ получения нанокапсул тимола
KR102244368B1 (ko) * 2020-03-30 2021-04-27 현대바이오사이언스 주식회사 비타민과 덱스판테놀이 봉입된 에토좀 조성물 및 이의 제조방법
CN111700883B (zh) * 2020-07-23 2021-04-06 深圳大佛药业股份有限公司 一种硫酸沙丁胺醇缓释型吸入制剂及其生产工艺
JP2022151426A (ja) * 2021-03-26 2022-10-07 均 石井 上気道炎治療薬。
JP2022151438A (ja) * 2021-03-26 2022-10-07 均 石井 外耳炎と中耳炎と内耳炎の治療薬。

Family Cites Families (41)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BE615889A (de) * 1952-04-15 1900-01-01
US4113857A (en) * 1977-05-16 1978-09-12 The Purdue Frederick Company Process for the preparation of iodophor compounds and methods for stabilizing iodophor pharmaceutical compositions containing the same
US4675009A (en) * 1977-11-07 1987-06-23 Lec Tec Corporation Drug dispensing device for transdermal delivery of medicaments
US4235871A (en) * 1978-02-24 1980-11-25 Papahadjopoulos Demetrios P Method of encapsulating biologically active materials in lipid vesicles
FR2536278A1 (fr) * 1982-11-18 1984-05-25 Dupont Michele Nouvelle composition therapeutique utile notamment pour la cicatrisation des plaies
US4704383A (en) * 1983-12-29 1987-11-03 The Research Foundation Of State University Of New York Non-antibacterial tetracycline compositions possessing anti-collagenolytic properties and methods of preparing and using same
FR2581542B1 (fr) * 1985-05-07 1988-02-19 Oreal Compositions topiques destinees au traitement de la peau a base de derives de l'acide salicylique
FR2591105B1 (fr) * 1985-12-11 1989-03-24 Moet Hennessy Rech Composition pharmaceutique, notamment dermatologique, ou cosmetique, a base de phases lamellaires lipidiques hydratees ou de liposomes contenant un retinoide ou un analogue structural dudit retinoide tel qu'un carotenoide.
SE8603812D0 (sv) * 1986-09-12 1986-09-12 Draco Ab Administration of liposomes to mammals
US5049388A (en) * 1986-11-06 1991-09-17 Research Development Foundation Small particle aerosol liposome and liposome-drug combinations for medical use
US4938965A (en) * 1987-07-22 1990-07-03 Her Majesty The Queen In Right Of Canada, As Represented By The Minister Of National Defence Of Her Majesty's Canadian Government Ocular delivery of prophylactic agents
US5246708A (en) * 1987-10-28 1993-09-21 Pro-Neuron, Inc. Methods for promoting wound healing with deoxyribonucleosides
DE3826946C1 (de) * 1988-08-09 1990-03-15 A. Nattermann & Cie Gmbh, 5000 Koeln, De
US4906476A (en) * 1988-12-14 1990-03-06 Liposome Technology, Inc. Novel liposome composition for sustained release of steroidal drugs in lungs
US5006343A (en) * 1988-12-29 1991-04-09 Benson Bradley J Pulmonary administration of pharmaceutically active substances
US5232692A (en) * 1989-04-28 1993-08-03 Research And Education Institute, Inc. Povidone-iodine neonatal ophthalmic antimicrobial prophylactic agent
ES2060040T5 (es) * 1989-05-31 1999-09-16 Fisons Plc Dispositivo y formulacion de inhalacion de medicamento.
US5089389A (en) * 1989-08-25 1992-02-18 Eastman Kodak Company Buffered composition, coated article test device and a method for their use
US5128139A (en) * 1991-02-15 1992-07-07 Nu Skin International, Inc. Composition containing liposome-entrapped grapefruit seed extract and method for making
DE4111982C2 (de) * 1991-04-12 1998-12-24 Merz & Co Gmbh & Co Stabile kleinpartikuläre Liposomenzubereitungen, deren Herstellung und Verwendung
DE69222847T3 (de) * 1991-04-16 2005-09-15 Nippon Shinyaku Co., Ltd. Verfahren zur herstellung einer festen dispersion
ATE221379T1 (de) * 1991-05-01 2002-08-15 Jackson H M Found Military Med Verfahren zur behandlung infektiöser respiratorischer erkrankungen
AU4066693A (en) * 1992-12-23 1994-07-19 Bernhard Hugemann Compacted drug body for use in the mechanical generation of inhalable active-substance particles
US5552158A (en) * 1993-02-23 1996-09-03 Norac Technologies Inc. Skin care composition
DE4306475A1 (de) * 1993-03-02 1994-09-08 Ensenat Pedro Gonzalez Liposomen, enthaltend Chlorhexidindiacetat oder Chlorhexidindigluconat
WO1994028876A1 (en) * 1993-06-07 1994-12-22 Advanced Therapies, Inc. Liposome powders
US5512269A (en) * 1993-06-09 1996-04-30 Burroughs Wellcome, Co. Method of treating retained pulmonary secretions
US5456904A (en) * 1993-06-28 1995-10-10 The Procter & Gamble Company Photoprotection compositions comprising certain chelating agents
US5863556A (en) * 1993-08-20 1999-01-26 Euro-Celtique, S.A. Preparations for the external application of antiseptic agents and/or agents promoting the healing of wounds
DE9312509U1 (de) * 1993-08-20 1993-10-28 Euro Celtique Sa Präparate zur äußeren Verabreichung von antiseptischen und/oder die Wundheilung fördernden Wirkstoffen
WO1996014083A1 (de) * 1994-11-04 1996-05-17 Polymun Scientific Immunbiologische Forschung Gmbh Applikation von sod in liposomen
US5744457A (en) * 1995-03-31 1998-04-28 Hamilton Civic Hospitals Research Development Inc. Compositions and methods for inhibiting thrombogenesis
JPH08301774A (ja) * 1995-05-08 1996-11-19 Kowa Co 喉用殺菌消毒薬
WO1998055104A1 (fr) * 1997-06-06 1998-12-10 Shionogi & Co., Ltd. Perfectionnement d'un systeme d'administration de medicament
ES2341532T3 (es) * 1999-05-27 2010-06-22 Euro-Celtique S.A. Preparacion con povidona yodada para el tratamiento de heridas.
WO2000072823A1 (en) * 1999-05-27 2000-12-07 Euroceltique S.A. Preparations for the application of anti-inflammatory agents
US7297344B1 (en) * 1999-05-27 2007-11-20 Euro-Celtique, S.A. Preparations for the promotion of wound healing in the upper respiratory tract and/or ear
US7300667B1 (en) * 1999-05-27 2007-11-27 Euro-Celtique, S.A. Preparations for the application of anti-inflammatory, especially antiseptic agents and/or agents promoting the healing of wounds, to the lower respiratory tract
US6497896B2 (en) * 2001-02-12 2002-12-24 Supergen, Inc. Method for administering camptothecins via injection of a pharmaceutical composition comprising microdroplets containing a camptothecin
ES2292874T3 (es) * 2003-05-19 2008-03-16 Euro-Celtique S.A. Composiciones liposomales secas de pvp-yodo.
US8435261B2 (en) * 2009-07-15 2013-05-07 Regents Of The University Of Minnesota Treatment and placement device for sinusitis applications

Also Published As

Publication number Publication date
HUP0102337A3 (en) 2002-12-28
HK1035336A1 (en) 2001-11-23
IL139229A0 (en) 2001-11-25
PT1079806E (pt) 2006-06-30
PT1079807E (pt) 2007-01-31
RU2211693C2 (ru) 2003-09-10
WO1999060998A1 (en) 1999-12-02
EP1079807B1 (de) 2006-09-13
DE69930259T2 (de) 2006-11-23
CN1303271A (zh) 2001-07-11
JP2002516266A (ja) 2002-06-04
HU226729B1 (en) 2009-08-28
DK1079807T3 (da) 2007-01-22
DE29923848U1 (de) 2001-04-12
BR9911072A (pt) 2001-02-06
JP2002516269A (ja) 2002-06-04
US20120009253A1 (en) 2012-01-12
ES2260915T3 (es) 2006-11-01
RU2212884C2 (ru) 2003-09-27
EP1083886A1 (de) 2001-03-21
CA2332369A1 (en) 1999-12-02
KR100613706B1 (ko) 2006-08-21
IL139231A0 (en) 2001-11-25
IL139230A0 (en) 2001-11-25
DE69933208T2 (de) 2007-08-30
DE29923847U1 (de) 2001-04-12
HK1035335A1 (en) 2001-11-23
HU226710B1 (en) 2009-07-28
CA2332371A1 (en) 1999-12-02
CY1105834T1 (el) 2011-02-02
CN1303276A (zh) 2001-07-11
ATE339187T1 (de) 2006-10-15
AU752018C (en) 2003-10-09
HUP0102899A2 (hu) 2002-03-28
AU759264B2 (en) 2003-04-10
DE29923766U1 (de) 2001-06-07
HUP0102892A3 (en) 2002-12-28
DK1079806T3 (da) 2006-07-17
CN1303272A (zh) 2001-07-11
EP1079807A1 (de) 2001-03-07
EP1079806A1 (de) 2001-03-07
US20080038330A1 (en) 2008-02-14
JP4741726B2 (ja) 2011-08-10
BR9911070A (pt) 2001-02-06
HUP0102899A3 (en) 2002-12-28
KR20010043821A (ko) 2001-05-25
AU4370699A (en) 1999-12-13
AU4370499A (en) 1999-12-13
AU752018B2 (en) 2002-09-05
CA2332389C (en) 2008-09-09
ATE319427T1 (de) 2006-03-15
IL139230A (en) 2007-07-24
DE69930259D1 (de) 2006-05-04
HUP0102337A2 (hu) 2002-03-28
AU4266799A (en) 1999-12-13
AU747877B2 (en) 2002-05-30
JP4741727B2 (ja) 2011-08-10
KR20010043819A (ko) 2001-05-25
WO1999060999A1 (en) 1999-12-02
RU2202340C2 (ru) 2003-04-20
EP1083886B1 (de) 2003-04-02
HUP0102892A2 (hu) 2002-03-28
BR9911071A (pt) 2001-02-06
EP1079806B1 (de) 2006-03-08
DE69906518D1 (de) 2003-05-08
JP2002516265A (ja) 2002-06-04
WO1999061003A1 (en) 1999-12-02
CA2332389A1 (en) 1999-12-02
DE69933208D1 (de) 2006-10-26
KR100445146B1 (ko) 2004-08-18
KR20010043820A (ko) 2001-05-25
ES2273493T3 (es) 2007-05-01

Similar Documents

Publication Publication Date Title
ATE235895T1 (de) Arzneistoff-abgabesystem enthaltend eine festgepackte, feste arzneistoffbasis
CY1105707T1 (el) Συνδυασμοι φορμοτερολης και ενος αλατος τριοτροπιου
BR0115965A (pt) Composições farmacêuticas para a liberação oral de agentes farmacologicamente ativos
HUP0402217A2 (hu) Platinaszármazékot tartalmazó gyógyászati készítmények
NZ516347A (en) Indanyl-substituted benzenecarboxamides, process for their preparation, their use as a medicament and pharmaceutical formulations containing them
HUP9802339A2 (hu) Darifenacint tartalmazó gyógyászati készítmények
PT693924E (pt) Processos para administracao (in vivo) de substancias biologicas e composicoes utilizadas nestes processos
BR9912694A (pt) Composto para preparar medicamento de administração pulmonar
DE60121301D1 (de) Flibanserin zur Behandlung extrapyramidaler Bewegungsstörungen
CY1105849T1 (el) Χρηση αντισηπτικων στην εμπορικη κατασκευη φαρμακευτικου παρασκευασματος προς αποτροπη ή θepαπεια εναντι φλεγμονων εντος του ανθρωπινου σωματος
SE9901573D0 (sv) New compounds
DE50203456D1 (de) Deuterierte 3-piperidinopropiophenone sowie diese verbindungen enthaltende arzneimittel
ATE458471T1 (de) Formulierungen mit povidon-iod zur behandlung von wunden
ATE13488T1 (de) Gallium-chlorid, ein neues antikrebsmittel.
GEP20043377B (en) Pharmaceutical Complex
ATE256134T1 (de) Sulfatierte phosphatidylinositole, ihre herstellung und verwendung
BR0009327A (pt) Composição farmacêutica para a terapia de sintomas do trato urinário inferior
DE60041004D1 (de) Abführzusammensetzung,welche l-arginine enthält
ZA200600165B (en) Amino acid diamides in non alpha position useful as adjuvants for the administration of active biological agents
WO2003066806A3 (en) Therapeutic use of aziridino compounds
FI823762A0 (fi) Pyridazinon-iminer och deras fysiologiskt godtagbara syraadditionssalter, foerfarande foer deras framstaellning och dessa foereningar innehaollande terapeutiska medel

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties